2025 International Congress Archives

Targeted Brain Delivery of Rifampicin via PEG-PLA Nanoparticles: A Promising Therapeutic Strategy for Neuroprotection and Disease Modification in Parkinsonian Mouse Models

JH. Su, EX. Tao (Shenzhen, China)
Targeting IGF2 Signaling for Immune Modulation of Microglia in Parkinson’s Disease

T. Huerta, V. Urbina, C. Aguilera, P. Chana, R. Vidal (Santiago, Chile)
Targeting inflammation and autophagy: a dual-inhibition strategy to reduce α-synuclein pathology in GBA1-associated Parkinson’s disease

T. Usenko, A. Bezrukova, K. Basharova, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)
Task Specific Embouchure Tremor in a Shakuhachi Player

J. Liu, T. Liu, M. Bruno (Honolulu, USA)
Tavapadon Is Not Associated With Increased Daytime Sleepiness in People With Parkinson’s Disease

R. Pahwa, Z. Mari, W. Ondo, L. Harmer, A. Lind, R. Hauser (Kansas City, USA)
Telehealth Follow-up for Craniofacial Dystonias Treated with Neurotoxin Injection: Physician Outcomes

K. Harper, L. Kopaeva, L. Venditti, J. Meystedt, M. Hacker, S. Sharp, P. Charles (Nashville, USA)
Telephone-Based Cognitive Screening for MCI to Dementia in Parkinson’s Disease

R. Ferrucci, A. de Sandi, F. Verardo, D. Mellace, A. Marfoli, S. Zago, E. Mailland, G. Pravettoni, F. Mameli, F. Ruggiero, E. Zirone, S. Marceglia, A. Priori, F. Cogiamanian, M. Vergari, C. Manzoni, E. Aiello (Milan, Italy)
Temporal disease patterns prior to Progressive Supranuclear Palsy diagnosis

M. Fu, T. Chang (Los Angeles, USA)
Temporal Trends in Parkinson’s Disease Related Mortality from 1999-2023: A National Analysis pre and post COVID

N. Bujala, R. Shi, J. Javeid, Z. Xu, F. Yu (New York, USA)
Temporomandibular Joint Balancing Therapy for Cervical Dystonia: A Retrospective Study

M. Park, YJ. Lee, H. Yoo, J. Hur, JW. Seo (Daejeon, Republic of Korea)
Tendencies of Non-Motor Symptoms and Short-Term Clinical Predictors in Patients with Parkinson’s Disease

R. Nakagawa, M. Shiraishi, N. Takao, H. Matsumoto (Kawasaki City, Kanagawa Prefecture, Japan)
The A53T mutation in alpha-synuclein impairs astrocytic metabolism and inflammatory response

S L. Pereira, M. Tziortziou, P. Mulica, S. Delcambre, L. Gallucci, L. Neises, M. Soudy, E. Glaab, M. Mendes, G. Dittmar, J. Meiser, A. Grünewald (Esch-sur Alzette, Luxembourg)
The Absence of Normal Pressure Hydrocephalus Imaging Features in US Veterans with Parkinsonism: A Retrospective Imaging Study

Y. Xu, J. Acquaviva, B. Puccio, T. Nygaard, W. Husar (Baltimore, USA)
The Alien Hand Syndrome in a Young Woman with Ischemic Stroke

A. Sim, Z. Luan, I. Fernande, S. Cruz-Flores, P. Piriyawat (El Paso, USA)
The application of Deep Brain Stimulation in KMT2B dystonia: Two cases with different targets

L. Okar, D. Johnson, S. Manivannan, P. Chand (St. Louis, USA)
The Association of Motor and Non-motor Factors on Ambulatory Activity in People with Parkinson disease

C. Lopez-Lennon, J. Hale, E. Suttman, A. Rosenfeldt, A. Jansen, J. Alberts, L. Dibble (Salt Lake City, USA)
The Associations between Cognitive Reserve Proxies, Multimodal MRI Brain Measures and Cognition, Motor Function and Mood in Parkinson’s Disease

I. Saywell, S. Sghirripa, A. Walls, A. Dwyer, B. Child, J. Salamon, S. Hansch-Maher, L. Collins-Praino, M. Jenkinson, I. Baetu (Adelaide, Australia)
The Benefits of Whole-Body Electro Muscle Stimulation (WB-EMS) in a patient with Parkinson’s Disease

N. Duff, C. Cawood, M. Noble (Parktown, South Africa)
The Bjorn Moller Research Repository: A Resource for Movement Disorders Research

S. Schaffner, A. Kuan, D. Felix, S. Appel-Cresswell (Vancouver, Canada)
The Burden of Spasticity in Adults with Cerebral Palsy in South Africa

M. Noble, D. Veliotes, C. Dafkin (Parktown, South Africa)
The cerebellum encodes dynamic motor frequencies for volitional movements

YM. Wang, CW. Liu, WC. Liu, MK. Pan (Taipei, Taiwan)
The Cholinergic System in Cervical Dystonia – An [18F]-FEOBV PET study

S. Lagerweij, J. Dalenberg, M. Smit, L. Centen, M. Coenen, M. van Egmond, E. de Vries, D. Peretti, M. Tijssen (Groningen, Netherlands)
The Cleveland Clinic-Virtual Home Environment (CC-VHE): A Reliable Way to Trigger Freezing of Gait in Parkinson’s disease

A. Rosenfeldt, M. Miller Koop, A. Bazyk, V. Berki, S. Nagel, B. Walter, J. Liao, K. Baker, J. Alberts (Cleveland, USA)
The Clinical Case of Acute Comorbidities in Parkinson’s Disease

P. Dynin, V. Yakovleva (Saint-Petersburg, Russian Federation)
The Clinicoradiological profile of patients with Osmotic Demyelination Syndrome and Movement Disorders

D. Dutta, H. Kumar, J. Ganguly, S. Mukherjee (Kolkata, India)
The Complexity of Neuropsychiatric Symptoms Assessment in Parkinson’s Disease: A Rasch Analysis of the Mild Behavioral Impairment-Checklist

Y. Song, L. Ronat, O. Monchi, Z. Ismail, G. Pinilla-Monsalve (Montreal, Canada)
The Cultural Validation of the Montreal Cognitive Assessment in Bangladeshi Adults with Parkinson’s Disease in East London

K. Dey, A. Shahid, M. Singh, A. Zirra, E. Camboe, R. Weil, D. Gallagher, C. Budu, T. Haque, S. Waters, S. Ali, N. Mukadam, C. Marshall, A. Noyce (London, United Kingdom)
The Diabetic Dance: Hemichorea-Hemiballismus Syndrome On The Hyperglycemic Stage; A Case Report

A. Kano (Zamboanga City, Philippines)
The Diagnostic Dilemma in ATP7B Heterozygosity

P. Kahali, C. Siskind, S. Karjagi, A. Negi, L. Yang, H. Bronte-Stewart, M. Ferris (Palo Alto, USA)
The differential transcriptomic signatures of substantia nigra in Parkinson disease and Multiple system atrophy

JH. Shin, KE. Ruhno, C. Shin, HJ. Kim, JH. Moon, HJ. Kim (Seoul, Republic of Korea)
The discrepancy between self-reported hyposmia and objective assessment by Sniffin’ sticks in high risk of synucleinopathies and healthy controls.

J. Sringean, S. Phumphid, C. Anan, J. Meesri, P. Rattanajun, S. Wehhinhiran, A. Chantadunga, T. Sanengmanee, R. Bhidayasiri (Bangkok, Thailand)
The Dutch Yips Study- part V: The VIdeo Panel (VIP)-Study

E. van Wensen, B. Nijenhuis, E. van Leeuwen, J. Zwerver, M. de Koning-Tijssen, B. Vande Warrenburg, T. Schermer (Apeldoorn, Netherlands)
The Dystonia Coalition: Natural History & Biorepository Projects Update

J. Perlmutter (St Louis, USA)
The East London Parkinson Disease Project: cultural fairness of common cognitive screening tests

A. Zirra, KC. Dey, E. Camboe, E. Bhadra, T. Haque, S. Waters, DA. Gallagher, C. Budu, B. Huxford, C. Simonet, C. Edwards, S. Ali, R. Weil, N. Mukadam, AJ. Lees, T. Boyle, MT. Perinan, CR. Marshall, AJ. Noyce (London, United Kingdom)
The East London Parkinson Disease Project: Higher Immune Activation found in Patients with Parkinson’s Disease Dementia from a Diverse Population

A. Zirra, KC. Dey, E. Camboe, E. Bhadra, B. Huxford, R. Laban, N. Donkor, F. Nice, S. Valle Thomas, A. Gaspariunas, L. Mitchell, DA. Gallagher, C. Budu, C. Simonet, T. Boyle, AJ. Lees, D. Yadin, J. Dias, O. Cavlan, CR. Marshall, MT. Perinan, AJ. Noyce (London, United Kingdom)
The Effect of Body Position on Cortical and Peripheral Neurophysiology of Adductor-type Laryngeal Dystonia: A Pilot Study

J. Pierce, R. Gillam, B. Kirwan, A. Dorval, A. Hancock, A. Stark, D. Legler, H. da Silva, M. Smith, K. Simonyan, J. Barkmeier-Kraemer (Salt Lake City, USA)
The effect of continuous subcutaneous foslevodopa/foscarbidopa infusion on sleep in Parkinson’s disease: three case reports

H. Sakuramoto, H. Fujita, K. Suzuki (Shimotuga Mibu, Japan)
The Effect of Foslevodopa/Foscarbidopa Treatment on Nonmotor Symptom Burden in Advanced Parkinson’s Disease

I. Malaty, P. Odin, D. Kern, L. Bergmann, M. Shah, R. Gupta, A. Antonini, K. Chaudhuri (Gainesvile, USA)
The Effect of Melatonin on Sleep Quality and Daytime Sleepiness in Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

A. Zrineh, R. Akwan, MM. Elsharkawy, B. Douden, W. Sleibi, M. Eldesouki (Al-Quds, State of Palestine)
The effect of trial numbers on prism adaptation in Parkinson’s disease

K. Taneda, T. Shimizu, N. Tokuda, S. Moriyasu, T. Nakamura, T. Murakami, Y. Ugawa, R. Hanajima (Yonago, Japan)
The effect of vortioxetine and mirtazapine on levodopa-induced dyskinesia in a rat model of Parkinson’s disease

R. Tohge, S. Satoshi, Y. Yakushiji (Osaka, Japan)
The effectiveness and safety of autologous adipose derived stromal vascular components (SVF) in the treatment of multiple system atrophy

ZL. Cai, RX. Li, JW. Li (Suzhou, China)
The Effectiveness of Drug-Disease Best Practice Advisory Alerts for Preventing the Administration of Contraindicated Medications in Patients with Parkinsonism

A. Kundrick, M. Fedorova, B. Sokola, B. Walter (Cleveland, USA)
The Effectiveness of Rivastigmine in Parkinson’s Disease: Impact on Motor Symptoms, Gait, Cognitive Function, and Falls – A Systematic Review and Meta-Analysis of Double-Blind, Placebo-Controlled RCTs

V. Byroju, J. Pitton Rissardo, A. Fornari Caprara (Camden, USA)
The Effects of Melatonin in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Double-Blind, Placebo-Controlled RCTs

V. Byroju, J. Pitton Rissardo, A. Fornari Caprara (Camden, USA)
The Effects of Multimodal Training on Sleep Architecture in Corticobasal Syndrome: A Case-Report

J. Cristini, F. Seo, A. Bon, L. Rodrigues, A. Dagher, R. Postuma, P. Rosa-Neto, J. Carrier, A. Amara, S. Steib, C. Paquette, M. Roig (Montreal, Canada)
The Effects of Non-pharmacological Treatments for Parkinson’s Disease Sleep Disorders：A Systematic Review and Meta-Analysis

Q. Zhao, Y. Yang, S. Bu, Z. Wang (Shanghai, China)
The Effects of Sex and Race on the Quality of Life of Parkinson’s Patients in Hawai’i

R. Shuman, E. Krening, M. Bruno, F. Gao, K. Thai, M. Faouzi, GW. Ross (Hawaii, USA)
The efficacy and safety of continuous subcutaneous infusion therapy with foslevodopa/foscarbidopa

M. Shiraishi, N. Takao, Y. Nakano, Y. Yamano (Kawasaki City, Japan)
The Efficacy of Neuromodulation for Motor Recovery in Children with Hemiparesis Due to Perinatal Stroke: A Systematic Review and Meta-Analysis.

I. Andrade, A. de Almeida (Vitória da Conquista, Brazil)
The feasibility and practical utility of virtual visits for patients with Parkinson’s disease in different World Regions

E. Cubo, J. Youn, J. Ahn, O. Ojo, N. Okubadejo, Z. Aldaajani, M. Essam, A. Shalash, A. Garcia, A. Cardozo, M. Spindler, Z. Mari (Burgos, Spain)
The Feedback Loop: Illness Perceptions and Motor Complications in Parkinson’s

V. Azoidou, L. Smith, A. Noyce, C. Simonet (London, United Kingdom)
The FGF14-SCA27B GAA•TTC Repeat Shows Marked Somatic Expansion in the Cerebellum

D. Pellerin, JL. Méreaux, S. Boluda, MC. Danzi, MJ. Dicaire, CS. Davoine, P. Iruzubieta, B. Hayward, D. Genis, G. Spurdens, JM. Hammond, BJ. Gerhart, M. Renaud, C. Bonnet, JS. Napierala, IW. Deveson, M. Napierala, K. Usdin, A. Brice, LM. Porcel, D. Seilhean, SL. Zuchner, H. Houlden, A. Durr, B. Brais (London, United Kingdom)
The financial limitations of fixed budget deep brain stimulation treatment in Hungary: Should we implant new patients or replace the old generators?

N. Kovacs, D. Pintér, T. Makó, I. Balás, I. Boncz, A. Schwarcz, M. Rohonczi, E. Bacsa (Pécs, Hungary)
The First cross-sectional comparative observational study of Sexual Dysfunction in Emirati and non-Emirati Parkinson’s disease Patients (EmPark-SD) in the United Arab Emirates

V. Metta, H. Benamer, T. Loney, H. Hussain, A. Nalarakettil, E. Awad, S. Kumar, C. Falup, R. Borgohain, R. Chaudhuri (London, United Kingdom)
The Frontalis Behavioral Trick in Blepharospasm

S. Yarlagadda, G. Berkmen, D. Boz, H. Jinnah, L. Scorr (Altanta, USA)
The Genetic and Phenotypic Spectrum of Primary Familial Brain Calcification in a large cohort from China

ZD. Cen, ZR. Lin, W. Luo (Hangzhou, China)
The Genetic Landscape of Parkinson’s Disease in African and Admixed Populations: Discovering Population-Specific Risk and Unveiling Etiological Insights

O. Ojo, N. Okubadejo, M. Makarious, S. Bandres-Ciga (Lagos, Nigeria)
The Genotypic and Phenotypic Spectrum of GOSR2 Mutations: Clinical and Pathophysiological Insights

S. Polet, L. Siegal, S. Fuchs, M. Tijssen, T. de Koning (Groningen, Netherlands)
The Global Parkinson’s Genetics Program: Expanding the Diversity of Neurological Disorder Data: 2025 Update

GP2. Parkinson'S_genetics_program (Chevy Chase, USA)
The heterogenous compatibility of FDG-PET patterns and tau deposition in vivo in patients with Corticobasal Syndrome

X. Li, JY. Lu, FT. Liu, J. Wang (Shanghai, China)
The identification of two novel intronic variants of the SPG4/SPAST gene with pathogenic effect reveals a novel genotype-phenotype correlation

A. Orlacchio, C. Evangelisti, M. Stasi, A. Meyyazhagan, P. Basavaraju, G. Ribas, N. Fava, S. Ramadan, M. Miele, R. Miyamoto, J. Pedroso, O. Barsottini, H. Teive, E. Panza (Bologna, Italy)
The Impact of Anodal transcranial Direct Current Stimulation on the Metabolomic Profiles of Cerebrospinal Fluid in Parkinson’s Disease

KW. Park, WY. Jang, KS. Jang, MR. Choi (Gangneung-si, Republic of Korea)
The Impact of Bilateral GPi Deep Brain Stimulation on Non-Motor Symptoms in Parkinson’s Disease

J. Lee, S. Jo, M. Choi, SJ. Chung (Goyang-si, Republic of Korea)
The Impact of Depression on Information Storage, Consolidation and Evocation Processes in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease without Dementia by Deep Brain Stimulation. Descriptive study of the ESDEPARK Scale.

C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, P. Andrea Gutiérrez-Lenis, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Villegas-Trujillo, S. Ordoñez-Cure, K. Alejandro Rivera-Quintero (Cali, Colombia)
The Impact of Freezing of Gait on Falls over time in Parkinson’s disease

A. Madamangalam, V. Lavu, J. Yu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesville, USA)
The Impact of Friedreich Ataxia Progression on Mobility

S. Kuo, S. Farooq, C. Harrod, J. Smith, M. Urbich, P. Pemberton-Ross, R. Lawson (New York, USA)
The Impact of Levodopa on Gait in Parkinson’s Disease: A Quantitative Analysis of Striatal Dopamine Transporter Availability and Lateralization

YS. Kim, DG. Park, JH. Yoon (Suwon, Republic of Korea)
The Impact of Metabolic Syndrome on Parkinson’s Disease Progression: A Systematic Review

T. Denicol, C. Dagostini, MF. Felippe, G. Guindani Maia, G. Dal Alba, J. Sánchez León, A. Hilbig, C. Mello Rieder (Porto Alegre, Brazil)
The Impact of Microgravity and Herpes Simplex Virus 1 on Parkinson’s Neurodegeneration and HERV Expression

ER. Simula, S. Jasemi, D. Cossu, I. Cossu, M. Fais, M. Noli, LA. Sechi (Sassari, Italy)
The Impact of Myofascial Release using Dry Needling on Gait in Parkinson’s Disease: A Pilot Study

A. Tahara, A. Gastaldi, A. Chinaglia, R. Monteiro, V. Tumas, P. Santiago (Ribeirão Preto, Brazil)
The Impact of Non Motor Symptoms on Physical Activity in Parkinson’s Disease.

S. Conklin, L. Vaikutis, T. Loux, L. Schwarz, J. Longhurst (Saint Louis, USA)
The Impact of Non-Invasive Brain Stimulation Timing on Physiotherapy Outcomes for Parkinson’s Disease a Systematic Review with Dose-Response Analysis

M. Guidetti, E. Ravizzotti, S. Giannoni-Luza, NV. Maiorana, S. Marceglia, T. Bocci, S. Oliveri, E. Pelosin, R. Pagani, AM. Previtera, A. Priori (Milan, Italy)
The Impact of Non-Motor Symptoms on Quality of Life in Early Parkinson’s Disease: A Prospective Study

F. Al-Zaidi (Almaty, Kazakhstan)
The Impact of Socioeconomic Status on Functionality in people with Parkinson’s Disease

A. Paixão, N. Pereira, R. Luz, E. Oliveira, I. Chaves, G. Vanucci, M. Piemonte (São Paulo, Brazil)
The Impact of Statin Therapy on Motor and Non-Motor Symptoms in Parkinson’s Disease: A Meta-Analysis

V. Byroju, J. Pitton Rissardo, A. Fornari Caprara (Camden, USA)
The IMPACT study: protocol of a randomised controlled single-blind trial evaluating efficacy and cost-effectiveness of telenursing in atypical parkinsonism

R. Cilia, V. Leta, F. Colucci, A. Suppa, F. Valentino, C. Terranova, C. Leuzzi, J. Cordasco, G. Fusi, S. Floridia, F. de Giorgi, R. Telese, A. Braccia, A. Zampogna, G. Pinola, M. Patera, G. Belluscio, S. Crivellari, E. Antoniazzi, S. Cascino, A. Giaco, A. Masaracchio, G. Moreschi, M. Catotti, R. Eleopra (Milan, Italy)
The Importance of a Through Serum Evaluation and Genetic Testing to Avoid Delays in Diagnosis of Chorea-acanthocytosis: A Case Report

A. Bossart, P. Kassavetis, J. Alshaikh (Salt Lake City, USA)
The importance of vascular anomalies and endothelin-1 factor in the development of vascular parkinsonism

R. Juraev, R. Matmurodov, S. Jumanazarova (Tashkent, Uzbekistan)
The influence of Caffeine intake on Type 2 Diabetes Mellitus mediated risk of Parkinson’s Disease.

K. Mallavarapu, E. Tan (Singapore, Singapore)
The Influence of Videography in the Foundation of Movement Disorders.

M. Rosso, D. Chu, B. Barton (New Haven, USA)
The MJFF PRKN/PINK1 Project

E-J. Vollstedt, A. Balck, AN. Basak, M. Brand, N. Brüggemann, J-C. Corvol, S. Ertan, M. Funayama, M. Gagliardi, N. Hattori, C-H. Lin, K. Lohmann, P. Mir, D. Narendra, G. Saranza, L. Stefanis, A-H. Tan, EM. Valente, S. Padmanabhan, K. Brockmann, C. Klein (Luebeck, Germany)
The Moroccan LRRK2 Registry: Building Resources to Investigate the Penetrance and Phenotype of LRRK2 in North Africans

Y. Razouqi, M. Megraoui, F. Belahsen, L. Bouguenouch, B. Elmakhzen, H. Ouhabi, J. Aasfara, Y. Zaid, A. Atpu, L. Khalki, M. Rizig (Casablanca, Morocco)
The Movement Disorders Society Unified Parkinson Disease Rating Scale Motor Subscore Is Not Associated With Future Parkinson Disease Milestones – an observational study using linked health administrative data

P. Gros, S. Bronskill, S. Dorrance, X. Wang, M. Chiu, M. Farkouh, C. Marras (Toronto, Canada)
The neuroprotective effects of Echinacoside on α-synuclein fibril-induced Parkinson’s disease mice model

Q. Zhao, S. Bu, Z. Wang, L. Jin (Shanghai, China)
The NICE-PD Trial: Cost-Effectiveness of Specialized Nursing Interventions for People with Parkinson’s Disease

D. Radder, B. Maas, E. Zeeboer, H. Lennaerts, L. Ter Brake, E. Adang, J. Int Hout, H. Vermeulen, T. van Asseldonk, C. Delnooz, R. Hagen, M. Munneke, B. Bloem, N. de Vries (Nijmegen, Netherlands)
The nurse-led future of Parkinson care: A thematic analysis of healthcare professionals’ experiences with nurse-led care implementation.

T. Peerbolte, D. Speelberg, B. Maas, I. van Noorden, L. Hoogendoorn, S. Darweesh, B. Bloem, S. vd Berg, N. de Vries, M. Meinders (Nijmegen, Netherlands)
The PDCogniCare Toolkit: Developing a harmonised neuropsychological toolkit specific to Parkinson’s Disease

E. Mccann, D. Pourzinal, D. Sriram, L. Mitchell, J. Liddle, A. Lehn, N. Dissanayaka (Herston, Australia)
The Phenomena of “Meryacheniye” and “Kliukushestvo” in Yakutia in the 20th Century

M. Andreev, S. Sleptsov, O. Polovinko (Moscow, Russian Federation)
The Phenotypic Spectrum of ATP1A3-Related Disorders: A Brazilian Cohort

V. Procaci, A. Gomes, R. Hora, P. Lima, J. Ferrer, D. Maia, F. Cardoso, H. Linden, M. Krueger, E. Leão, T. Tonholo Silva, P. Nóbrega, O. Barsottini, J. Pedroso (São Paulo, Brazil)
The Potential Long-Term Economic Impact of Continuous Monitoring in Parkinson’s Disease

S. Kontaxis, F. Kanellos, G. Rigas, N. Kostikis, S. Konitsiotis (Ioannina, Greece)
The Prevalence of Fibromyalgia in Functional Motor Disorder: A Single-Center Pilot Study

T. Serranova, L. Novakova, M. Jirasek, B. Krupkova, K. Sutorova, E. Ruzicka, M. Tinazzi, T. Sieger (Praha, Czech Republic)
The Radiographic Overlap Between Normal Pressure Hydrocephalus (NPH) and Progressive Supranuclear Palsy (PSP): When Looks Can Be Deceiving

R. Mani, C. Pol, M. Egnor, G. Schwartz (Stony Brook, USA)
The regulatory variant c.–253C>T of the DNAJC13 gene as a causal factor for Parkinson’s disease in a patient with early-onset

J. Hoenicka, A. Pascual, P. García-Ruíz, X. Castro-Martínez, R. Repossi, O. de Fabregues, L. Vela-Desojo, M. Mata, I. Torres, JC. Martinez-Castrillo, F. Palau, G. Fernandez (Mexico City, Mexico)
The Relationship among Depression, Self-Esteem, and Sense of Coherence in Patients with Parkinson’s Disease

Y. Ando, T. Yamawaki, Y. Ueki, S. Okuda, N. Tsuchikawa, K. Keiji, T. Kobayashi (HIroshima, Japan)
The Relationship Between Demographic and Clinical Characteristics with Disease Severity and Quality of Life in Parkinson’s Patients

R. Surbakti, A. Angelia, T. Lestarisa, A. Toemon, M. Anugerahny (Palangka Raya, Indonesia)
The relationship between synuclein-related biomarkers and people with upper-respiratory causes of hyposmia or persistent hyposmia

E. Brown, T. Tropea, A. Siderowf, L. Heathers, T. Foroud, C. Gochanour, C. Caspell-Garcia, M. Marshall, R. Kurth, T. Simuni, K. Marek, C. Tanner (San Francisco, USA)
The Role of Autophagy Lysosomal and Ubiquitin Proteasomal System in the Pathophysiology of Parkinson’s disease.

B. Adebisi (Akure, Nigeria)
The Role of Cognitive Impairment in the Effectiveness of Rehabilitation Training Programs for Parkinson’s Disease: A Review of Current Evidence

A. Elsayed, Z. Hegazy, K. Ahmed, O. Sabry, S. Elsenbawy, G. Abozeid, M. M. Elsayed (Mansoura, Egypt)
The Role of Depression and Anxiety in the Progression of Parkinson’s Disease

N. Dahodwala, C. Hurley, T. Kapogiannis, H. Cho, C. Caspell-Garcia, D. Weintraub, R. Dobkin (Philadelphia, USA)
The Role of Diet in the Relationship Between Hyposmia and Constipation in Patients with Parkinson’s Disease

J. Yu, S. Schaffner, J. Lam, S. Appel-Cresswell (Vancouver, Canada)
The Role of FGF14 GAA Repeat Expansions in Multiple System Atrophy: Frequency, Phenotypic Correlations, and Prognostic Implications

V. Chelban, D. Pellerin, N. Vijiaratnam, S. Sambin, M. Ostrozovicova, C. Girges, P. Leigh, L. Beichert, C. Bonnet, M. Renaud, W. Meissner, A. Sieben, D. Crosiers, P. Cras, S. Zuchner, J-C. Corvol, M. Farrer, M. Synofzik, B. Brais, T. Warner, H. Morris, Z. Jaunmuktane, T. Foltynie, H. Houlden (London, United Kingdom)
The role of imaging in deep brain stimulation programming: a preliminary comparative study of image-guided vs. neuroimaging-guided automated approaches in Parkinson’s disease

J. Bejarano Hernandez, A. Sánchez Gómez, A. Martinez Reyes, F. Valldeoriola Serra (Barcelona, Spain)
The role of interoception in motor imagery in Parkinson’s disease

J. Bek, M. Lavasidis, N. Brady, T. Welsh (Dublin, Ireland)
The Role of Knowledgeable Informants in the Early Detection of Parkinson’s Disease

E. Trinh, K. Harrison, M. Korell, C. Meng, E. Brown, K. Comyns, X. Chen, M. Bock, L. Racelo, G. Stebbins, C. Tanner (San Francisco, USA)
The Role of Mitochondrial DNA Haplogroups in determining the Age of Onset in Indian SCA2 Patients.

A. Sonakar, C. Sharma, S. Reza, S. Pandey, M. Srivastava, M. Faruq, A. Srivastava (New Delhi, India)
The Role of Neuropsychiatric Symptoms in the Diagnosis of Early Parkinson’s Disease: a Systematic Review

J. Vasconcelos Silva, G. Guindani Maia, MA. de Brito, AC. Prudente (Porto Alegre, Brazil)
The Role of Physiotherapy in Demystifying Parkinson’s Disease and Movement Disorders in Uganda.

S. Nakisanze, J. Mutunzi, E. Jjuuko (Masaka, Uganda)
The Role of Polygenic Background and APOE E4 in Monogenic and Idiopathic Parkinson’s Disease

M. Kmiecik, M. Holmes, P. Fontanillas, G. Riboldi, R. Schneider, J. Shi, A. Guan, S. Tat, K. Stagaman, J. Gottesman, D. Hinds, J. Tung, S. Aslibekyan, L. Norcliffe-Kaufmann (Sunnyvale, USA)
The Role of Research and Genetics Educational Events in Parkinson’s Research: Overcoming Barriers in the Hispanic Community

A. Coral-Zambrano, M. Rodriguez Violante, J. Orozco Velez, M. Inca Martinez, I. Mata, P. Hodges, R. de León (Miami, USA)
The role of serotonergic mechanisms in the formation of levodopa-induced drug-induced dyskinesias in Parkinson’s disease

D. Pulatova, F. Saidvaliev (Tashkent, Uzbekistan)
The Role of Sex in Cognitive Impairment, Depression, Anxiety, Hallucinations, Disease Severity and Sleep Disorder Symptoms in Parkinson’s Disease: A Mexican Cohort Study

A. Fierro-Ruiz, A. Solari-Capra, A. Steven-Garcia, P. Reyes-Perez, A. Lázaro-Figueroa, E. Morelos Figaredo, C. Guerra-Galicia, I. Estrada-Bellmann, K. Salinas-Barboza, Y. Matuk-Pérez, N. Gandarilla-Martínez, U. Caballero-Sánchez, P. Montes-Alcantara, V. Flores-Ocampo, I. Espinoza-Mendez, A. Zayas-Del-Mora, E. Gaspar-Martinez, E. Waldo, T. Leal, M. Inca-Martinez, I. Mata, S. Alcauter, A. Medina-Rivera, A. Ruiz-Contreras (Querétaro, Mexico)
The Role of Simulation-Based Learning in Enhancing Clinical Skills for Managing Parkinson’s Disease in Medical Education: A Systematic Review

A. Elsayed, A. Abdelsalhin, M. Mustafa, N. Elmestkawy, O. Hafez, N. Abdeltawab, M. Alomari, M. M. Elsayed (Mansoura, Egypt)
The Role of the Immune System in Dystonia: Insights from HLA genotyping

M. Lindloge, L. Scorr, B. Laabs, D. Ellinghaus, A. Franke, H. Jinnah, C. Klein, K. Lohmann (Altanta, USA)
The Role of α7 Nicotinic Acetylcholine Receptor in Mitochondrial Homeostasis and Neuroprotection

I. Goglia, Z. Landoulsi, P. May, M. Tziortziou, S L. Pereira, A. Grünewald (Esch-sur Alzette, Luxembourg)
The Sedentary Index (SI) for Daily Life Activity Monitoring in Progressive Supranuclear Palsy (PSP)

M. Dale, C. Silva-Batista, A. Ragothaman, Z. Nhem, A. Lawston, G. Harker, D. Maxwell, C. Speirs, D. Loudon, M. Mancini (Portland, USA)
The Severity and Burden of Movement Disorder Symptomology in Patients with Cerebrotendinous Xanthomatosis: A US-based Survey

F. Eichler, R. Hanke, C. Higuera, B. Wishart, B. Blanchard, G. Bryce, N. Odedara, S. Laurie, R. Dutta, J. Terner-Rosenthal, R. Aguilar, T. Pramparo, J. Pickford (Boston, USA)
The sphingolipid Lyso-Gb3, a biomarker for the lysosomal storage disorder Fabry Disease, is significantly elevated in blood from patients with Parkinson’s Disease

C. Beetz, C. Cozma, M. Iurascu, S. Fischer, S. Oppermann, K. Kandaswamy, P. Bauer (Rostock, Germany)
The Syn-D Study: Detection of Cutaneous Phosphorylated Alpha-Synuclein and blood P-Tau 217 in Patients with Mild Cognitive Impairment

C. Gibbons, T. Levine, B. Bellaire, R. Freeman (Boston, USA)
The Syn-Sleep Study Detection of Cutaneous Phosphorylated Alpha-Synuclein in REM Sleep Behavior Disorder

T. Levine, B. Bellaire, R. Freeman, C. Gibbons (scottsdale, USA)
The Trembling Descent: Down the Stairs Dystonia in Galactosemia

D. Menghani, R. Vasireddy, Z. Guduru (Lexington, USA)
The Unique Clinical Profile of Dystonia in Parkinson Disease

L. Xavier, A. Eid, H. Hwang, J. Perlmutter, P. Kotzbauer, M. Campbell, S. Norris (Saint Louis, USA)
The Unlikely Treatable A Case of Ataxia

V. Quintana, S. Bonilla, L. Carvajal, J. Nastasi Catanese, . , . (Cali, Colombia)
The use of interleaving stimulation as an advanced DBS programming strategy in movement disorders

R. Burke, P. Graese, P. Zeilman, J. Wong (Gainesville, USA)
The value of PET imaging in Parkinson’s disease with cognition impairment

T. Hu, Y. Tang, J. Wang (Shanghai, China)
The Vodka Trial: Clinical and Genetic Characteristics of Alcohol Responsiveness in Laryngeal Dystonia

L. O'Flynn, A. Domingo, A. Hamzehei Sichani, A. Nishiyama, M. Hincher, R. Yadav, L. Ozelius, K. Simonyan (Boston, USA)
Therapeutic Effect and Mechanism of Targeted Nano-selenium in Mouse Model of Parkinson’s Disease Induced by MPTP

W. Bi, L. Zhu, T. Chen, Y. Cen, J. Zou, Z. Su (Guangzhou, China)
Therapeutic Efficacy of Human Dental Pulp Stem Cells-Derived Exosome-Encased Phloroglucinol In MPTP-Induced Chronic Parkinsonian Rat model: Potential for Disease Modification

I. Datta, K. Mondal, R. Ghanty, G. Wagmare, A. Mahadevan, R. Santhoshkumar, N. Bn (Bengaluru, India)
Therapeutic Potential of GLP-1 Receptor Agonists in Parkinson’s Disease: A Systematic Review and Meta-Analysis

A. Badran, M. Gbreel (Cairo, Egypt)
Theta and Beta Oscillations Track Happiness and Surprise in the Subthalamic Nucleus After Reward Outcome

S. Brener, G. Feng, C. Merrick, B. Blain, R. Rutledge, S. Little (New Haven, USA)
Theta burst transcranial ultrasound stimulation of internal globus pallidus and motor cortex in Parkinson’s disease

YY. Lin, N. Raies, T. Grippe, A. Bhattacharya, C. Sarica, G. Darmani, R. Chen (Taoyuan City, Taiwan)
Theta-Burst Subthalamic Deep Brain Stimulation for Parkinson’s Disease: A Pilot Study of Motor and Cognitive Effects

X. Mason, K. Wu, M. Abu-Zahra, W. Choi, J. Cavaleri, R. Briggs, C. Mark, B. Lee, M. Wilson, D. Lee (Los Angeles, USA)
Theta-Burst Subthalamic Nucleus Deep Brain Stimulation Enhances Segregation of Cognitive Networks in Parkinson’s Disease

M. Abu-Zahra, S. Audrain, A. Barnett, K. Wu, W. Choi, K. Jann, C. Mark, R. Briggs, J. Cavaleri, B. Lee, X. Mason, D. Lee (Montreal, Canada)
Three Biopsies Optimizes Test Performance for the Detection of Cutaneous Phosphorylated Alpha-Synuclein

T. Levine, B. Bellaire, H. Khona, R. Freeman, C. Gibbons (scottsdale, USA)
Three Siblings with Progressive Cerebellar Ataxia Associated with a Rare PRKCG Variant

P. Avigan, J. Liu, L. Hogan, S. Frank, B. Benitez, L. Luo (Boston, USA)
Three-Year Single-Center Experience with Levodopa–Entacapone–Carbidopa Intestinal Gel in Advanced Parkinson’s Disease

J. Szász, V. Constantin, K. Orbán-Kis, S. Bataga, R. Neagoe, M. Ciorba, K. Kelemen, I. Mihály, S. Szatmári (TARGU MURES, Romania)
Time for a digital clock?

T. Turner, S. Crowley (Charleston, USA)
Time perception patterns in patients with Parkinson’s disease and Alzheimer’s disease

A. Chimagomedova, O. Levin (Moscow, Russian Federation)
Timing And Type Of Adverse Events Following Long-Term Treatment With Levodopa–Entacapone–Carbidopa Intestinal Gel (LECIG) Infusion – Data From The ELEGANCE Interim Analysis

N. Smith, B. Amlani (Reading, United Kingdom)
TMS-EEG Provides Objective Neurophysiological Measures of Motor Fluctuations in Parkinson’s Disease

M. Roitman, S. Anis, A. Suminski, N. Zifman, H. Fogel, T. Fay-Karmon, S. Hassin-Baer (Ramat Gan, Israel)
Topographical heterogeneity of cholinergic system status in Multiple System Atrophy: A series report

A. Narkis, G. Carli, J. Barr, R. Vangel, C. Spears, R. Albin, P. Kanel, N. Bohnen (Ann Arbor, USA)
Tourette – Like Phenotypes Following Combined Striatal Interneuron Loss.

C. Coll, J. Beccaria, B. Braz, A. Lopez Diaz, J. Belforte, M. Murer (Buenos Aires, Argentina)
Towards automated deep brain stimulation programming using neurophysiology and artificial intelligence

V. Lavu, J. Cagle, T. de Araujo, K. Johnson, C. de Hemptinne, J. Wong (Gainesville, USA)
Tracking Cognitive Decline and Understanding Study Dropout in PD-GBA

M. Bode, C. Pauly, S. Jónsdóttir, C. Schulte, B. Becker, B. Roeben, I. Wurster, S. Lerche, W. Poewe, R. Krüger, K. Brockmann, I. Liepelt-Scarfone (Tübingen, Germany)
Tracking cortical and peripheral beta bursts in Parkinson’s disease during DBS modulation

C. Graef, V. Rawji, N. Steadman, T. Foltynie, Y. Tai, R. Vaidyanathan, D. Farina, S. Haar (London, United Kingdom)
Tracking Physiological Biomarker Activity in the Globus Pallidus Internus in Two Dystonia Patients Implanted with Medtronic Percept™

S. Alberico, M. Berns, B. Pereira Rios, J. Aman, M. Park, D. Darrow, J. Vitek, L. Almeida (Minneapolis, USA)
Tracking Progression and Survival in a Large Cohort of Patients with Progressive Supranuclear Palsy

DP. Vaughan, R. Real, RG. Fumi, M. Theilmann Jensen, T. Revesz, Z. Jaunmuktane, T. Warner, A. Church, P. Leigh, E. Jabbari, H. Zetterberg, AJ. Heslegrave, E. Veleva, O. Swann, B. Ghosh, M. Hu, C. Kobylecki, P. Study Group, J. Rohrer, JB. Rowe, HR. Morris (London, United Kingdom)
Tracking The Role Of The Subthalamo-Temporal Network In Speech: A Deep Brain Stimulation-Electroencephalography Study

M. Mancuso, M. Fahimi, F. Mollaei, S. Maiti, T. Grover, H. Akram, M. Krueger, L. Zrinzo, T. Foltynie, V. Litvak, P. Limousin (London, United Kingdom)
Traditional Deep Brain Stimulation Programming versus Automated Image-Guided Algorithm in Patients with Parkinson’s Disease

H. Maghzi, C. Kim, S. Worthge, C. Malatt, M. Tagliati (Los Angeles, USA)
Trail Making Task in people with isolated REM sleep behaviour disorder

H. Chohan, T. Periñán, S. Waters, L. Pérez-Carbonell, G. Leschziner, J. Bestwick, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)
Trans-Spinal Theta Burst Magnetic Stimulation Enhances Treadmill Training Effects on Gait in Parkinson’s Disease

L. Lopes, J. Oliveira, A. Costa-Ribeiro, K. Monte-Silva, C. Souza, M. de Melo, M. Gomes, L. Shirahige, R. Albuquerque, R. Carra, C. Tanaka, E. Barbosa, D. de Andrade, R. Cury (Sao Paulo, Brazil)
Transcranial Direct Current Stimulation (tDCS) to Enhance Cognitive Function in Parkinson’s Disease: A Systematic Review and Meta-analysis with Implications for African Healthcare

O. Uwishema (Kigali, Rwanda)
Transcranial direct current stimulation combined with motor training for motor symptoms in Parkinson’s disease: a systematic review and meta-analysis

J. Jun, R. Kim (Seoul, Republic of Korea)
Transcranial Magnetic Stimulation as Treatment for Functional Movement Disorders: Experiences from a Single Centre Retrospective Audit

I. Osborne, J. Peters, S. Tisch (Darlinghurst, Australia)
Transcranial sonography in Parkinson’s disease patients

D. Khasanova, I. Khasanov, Z. Zalyalova (Kazan, Russian Federation)
Transcutaneous Afferent Patterned Stimulation: A Non-Invasive Approach to Modulate Brain Metabolism in Essential Tremor

M. Elgohary, K. Rosenbluth, P. Min, H. Shin, K. Lee (San Mateo, USA)
Transcutaneous Vagus Nerve Stimulation for Gait and Motor Function in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

J. Pitton Rissardo, A. Fornari Caprara (Camden, USA)
Transformation of Parkinson’s care through Self-Management, Remote monitoring and Timely review (SMaRT-PD): Care Pathway Mapping with Clinical Experts

N. Howe, P. Walker, C. Mutepfa, S. Pretorius, A. Ponzo, C. Carroll, J. Suklan (Plymouth, United Kingdom)
Traumatic DBS Implant exposure following head injury and its management – a case report.

A. Uppar (BANGALORE, India)
Treatment Of Advanced Parkinson’s With Levodopa–Entacapone–Carbidopa Intestinal Gel – Impact On Dyskinesia

B. Amlani, N. Smith (Reading, United Kingdom)
Treatment of Status Dystonicus with Deep Brain Stimulation in a Child with SOX2-Anophthalmia Syndrome

A. Morris, A. Viehoever (Saint Louis, USA)
Treatment Stability Across Different ADD-ON Therapies in Fluctuating Parkinson’s Disease

D. Rinaldi, E. Bianchini, S. Galli, G. Imbalzano, CA. Artusi (Rome, Italy)
Treatment with Mucuna pruriens Plus Solo Carbidopa Prescription in Patient Reluctant to Initiation of Traditional Levodopa/Carbidopa Medication

T. Denne (Mission Viejo, USA)
Tremor in Multifocal Motor Neuropathy

M. Qurbonova (Dushanbe, Tajikistan)
Tremor Predominant Presentation Of DYT-TOR1A

R. Kaur, A. Saini, R. Rajan, D. Garg, A. Elavarasi, A. Das, A. Srivastava, D. Radhakrishnan (New Delhi, India)
Trends in the incidence of Functional Movement Disorders (FMD):The impact of the pandemic and other historical events

G. Lopez, D. Marín Medina, M. Rossi, M. Merello (Buenos Aires, Argentina)
Trends in U.S. Drug Use Among Hospitalized Parkinson’s Patients Experiencing Delirium

H. Kamo, R. Burke, T. Mehta, M. Remz, M. Okun, C. Hess (Gainesvile, USA)
Trends on recruitment and retention in Parkinson’s Disease modification trials

D. Hengartner, R. Palacio, J. Garinger, A. Lysandropoulos (Durham, USA)
Trihexyphenidyl as a Treatment for Severe Freezing of Gait in Parkinson’s Disease: A Case Report

J. Ha, M. Ferris (Palo Alto, USA)
Tumeric and Curcumin Improve Motor Function and Reduce Catalepsy in a Rotenone -Induced Parkinson’s Disease Model

L. Darbinyan, L. Hambardzumyan, K. Simonyan, V. Sarkisian, L. Manukyan (Yerevan, Armenia)
Turkish Validity and Reliability Study of the Gastrointestinal Dysfunction Scale for Parkinson’s Disease

S. Irmak, H. Omercikoglu, D. Gunal (İstanbul, Turkey)
Turning Points in Disease Progression: Detecting MRI Biomarker Transitions in SCA3 Using Longitudinal Data

M. Ferreira, P. Wegner, T. Klockgether, J. Faber (Bonn, Germany)
Two Cases of SCN4A Temperature-Sensitive Sodium Channelopathy: From Dystonia to Myotonia

B. Talavera Esperanza, N. Chinchihualpa-Paredes, Z. Yu, A. Herrera, P. Vega, E. Hill, M. Kauffman, A. Espay, L. Marsili (Cincinnati, USA)
Tyrosine Hydroxylase Deficiency and Absence Epilepsy: An Association or Mere Coincidence?

L. Rieder, A. Schuh, C. Rieder, M. Bianchin (Canoas, Brazil)